2/2
08:00 am
nspr
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
2/2
07:44 am
nspr
InspireMD initiated with a Buy at Maxim
Medium
Report
InspireMD initiated with a Buy at Maxim